Evonik is one of the world leaders in the specialty chemicals industry. Active in more than 100 countries around the world, Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. We contribute small amounts of material that make a big difference. We provide the highest quality cell culture media ingredients for biologic drugs development & manufacturing, produce lipid nanoparticles essential in mRNA-based COVID-19 vaccines, make tires more fuel-efficient, and animal feeds healthier. As one of the key growth regions, Evonik has a strong production and R&D footprint in Asia Pacific. With over 5,000 employees at more than 50 production sites, the region contributed to €3.4 billion sales in 2021.
At Evonik, we offer high-quality cell culture solutions to pharmaceutical and biotech companies to help them boost cell culture performance in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors such as the adeno associated viral (AAV) vectors for gene therapy.
Commercially proven for reliable media performance across countless biological programs, our cQrex® portfolio features a range of peptides and keto acids designed to address key issues in mammalian cell culture.
Our latest offering, plant-derived cholesterol PhytoChol® Biopharma, which has been especially developed for use in animal-free cell culture media formulation, for example in chemically defined media which do not use fetal bovine serum (FBS). In addition, specialty carbohydrates like D-Mannose can be used as alternative energy sources and building blocks for intracellular protein glycosylation, enabling a higher flexibility in the production of therapeutic proteins.
All these cell culture ingredients are non-animal derived, readily available at commercial scale and can be customized to address specific project needs.
Learn more about Evonik’s cell culture expertise at https://healthcare.evonik.com/en/biopharma/cell-culture.